Protein Potential
Protein Potential
Protein Potential

Welcome to Protein Potential

Protein Potential's Research and Development Group focuses on producing intellectual property and recombinant bacteria, recombinant protein, and DNA products. Protein Potential's primary focus is on development of vaccines to protect against enteric diseases including shigellosis, diarrhea caused by ETEC, and typhoid fever and bioterrorism agents using its platform technology of recombinant, acid-stabilized Ty21a. Protein Potential is also developing subunit vaccines for Plasmodium falciparum and Plasmodium vivax malaria.

Protein Potential's Products and Services Group provides pharmaceutical and biotechnology companies, and government and academic institutions with high quality, purified Protein PotentialTM recombinant proteins and DNA plasmids for research and development. Protein Potential also provides process development, documentation, and technological know-how to transition therapeutic, vaccine, and diagnostic proteins and DNA plasmids to large-scale cGMP (Good Manufacturing Practices) manufacture (Protein PotentialTM service packages).

News and Media

Protein Potential Publishes on its Anthrax and Shigellosis Vaccines Based on Oral Typhoid Fever Vaccine Platform
> Press Release

Aduro Biotech and Protein Potential Present Data Demonstrating Novel Vaccine Offers 100% Protection in Malarial Model
> Press Release

Protein Potential awarded
multiple grants and awards since 2004
> See the list

Protein Potential awarded
multiple grants and awards since 2004
> See the list

President & CSO Dr. Kim Lee Sim
featured in Malaymail Online Article, The Nyonya who is saving the world from malaria
> Article

 

Copyright © 2018 Protein Potential, LLC - All rights reserved